Delivery Order SPE2DB22D1017-SPE2DB24FF0VT

Award Date 1/5/24
Potential Completion Date 1/8/24
Potential Value $4.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX RABIES VACCINE VIALS. The award has a potential value of $9,834.96 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. This delivery order is issued under a larger indefinite...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMOVAX RABIES VACCINE VIALS. The contract has a potential value of $5,866.77 and a completion date of March 7, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX rabies vaccine vials. The contract has a ceiling value of $1,942.83 and a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. In addition to this delivery order, Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX Rabies Vaccine vials. The $2,590.44 order has a completion date of January 9, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous DLA contracts to supply pharmaceuticals, medical supplies, and distribution services. This delivery order is part of the company's...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX RABIES VACCINE VIALS. The $24,337.07 contract has a completion date of January 10, 2024. Amerisourcebergen Drug Corp, operating out of its corporate office in Conshohocken, Pennsylvania, has received numerous previous contract awards from the DLA to supply pharmaceuticals, medical supplies, and...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX RABIES VACCINE VIALS. The contract has a potential value of $2,158.70 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with a larger contract vehicle. No set-aside designation was used. Amerisourcebergen Drug Corp is a...
The Defense Logistics Agency (DLA) awarded a Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX Rabies Vaccine Vials. The contract, valued at $3,238.05, has a Firm Fixed Price pricing type and an ultimate completion date of May 14, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,481.38 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX rabies vaccine vials. The contract has a completion date of January 8, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contracts from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services. This...
This contract award for $37,099.06 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of IMOVAX RABIES VACCINE VIALS, with a completion date of September 3, 2024. This contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. The contract has a Firm Fixed Price...
The Defense Logistics Agency (DLA) awarded a $36,705.99 firm fixed price delivery order to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distributor Amerisourcebergen Corporation. The award is for the provision of IMOVAX rabies vaccine vials, with a completion date of February 28, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31,...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF0VT
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $4,481.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMOVAX RABIES VACCINE VIALS. The delivery order was issued against an indefinite delivery contract held by Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities. No set-aside designation was used for this award. The period of performance extends through January 8, 2024, with the order being placed on January 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing a range of pharmaceutical and medical products and distribution services to support Department of Defense medical programs.

Generated 4/5/24, 9:12 AM